Advancing Care of Heart Failure and Chronic Kidney Disease with Non-Steroidal MRAs

Uncontrolled hypertension can lead to severe complications such as chronic kidney disease (CKD), heart failure, and stroke, including lethal outcomes. In 2019, high systolic blood pressure was the leading risk factor for global attributable deaths in females and the second leading risk factor in males, accounting for 10.85 million deaths.

Treating hypertension and associated conditions effectively is therefore highly important. This webcast was recorded live at our Sciarc symposium at the World Hypertension Congress 2025 and updates you on current study data and innovative approaches to tackling heart failure and chronic kidney disease as common consequences of hypertension.

8 March 2025

Chennai, India

Non-steroidal MRAs in heart failure management: Practical considerations and future directions

Speaker: Prof. Michael Böhm

Homburg/Saar, Germany

Lectures

Prof. Roland Schmieder

Prof. Roland Schmieder

Erlangen, Germany

Bridging gaps for treatment of heart failure and chronic kidney disease – Key characteristics of non-steroidal MRAs

Watch Lecture
Prof. Per-Henrik Groop

Prof. Per-Henrik Groop

Helsinki, Finland

Pioneering outcomes for improved heart failure and CKD: Treatment with finerenone

Watch Lecture
Prof. Michael Böhm

Prof. Michael Böhm

Homburg/Saar, Germany

Non-steroidal MRAs in heart failure management: Practical considerations and future directions

Current Lecture

CME test for this e-learning activity


More Information about this Education Module
Start ECMEC-test

Information on Funding



Show

These lectures are available as an EACCME-certified webcast from May 22, 2025 to May 22, 2027.

Downloads

Literature